Just a few more days ...

... and the 5th Helmholtz-Nature Medicine Diabetes Conference will welcome high-ranking scientists and young researchers of the international diabetes scene here in Munich. For both groups, the conference will offer plenty of opportunities to discuss questions and new findings in the field of diabetes research.

Everyone will benefit and return to work highly motivated with new inputs. For some of the young investigators, these three days will help them step up to a new career level. They were nominated to give a short presentation of their latest results before a high-ranking diabetes expert jury. The best of this group will receive the Novo Nordisk-Helmholtz Young Investigator in Diabetes Award, for short HeIDi.

Concept and contents by Sonja Duggen

Any suggestions or questions? Tweet us @helmholtzMucEn

Additional information at: #HelmholtzDiabetes2017



When the Helmholtz-Nature Medicine Diabetes Conference was first launched, Dr. Scott Sternson from the Janelia Farm Research Campus, USA and Dr. Matthew Hirschey from Duke University, USA won the HeIDi Award.

Scott Sternson is looking at the origins of our most fundamental motivations: behaviors, such as hunger and thirst, that are physiologically imperative for survival. To decipher the neurobiology of these survival needs, his lab group uses a combination of advanced molecular and systems neuroscience approaches. His findings could have an important impact on how to avoid obesity.
(first person on the left)

Matthew Hirschey’s research focuses on the mitochondrial metabolism, with a particular interest in how cells use metabolites and chemical modifications to sense metabolism.
(second person on the right)



More about Sternson:


More about Hirschey:


Photo from left to right:
Scott Sternson, Günther Wess, CEO Helmholtz Zentrum München, Uli Stilz, Vice President, Novo Nordisk A/S, Matthew Hirschey, Matthias Tschöp, Organizer of the Helmholtz-Nature Medicine Diabetes Conference, Helmholtz Zentrum München


The following year, Dr. Shingo Kajimura from the University of California San Francisco and Dr. Brian Finan, who was then working at Helmholtz Zentrum München, were honored.

Brian Finan conducts research on therapeutic drug strategies against diabetes and obesity. A multihormone molecule he helped develop combines the positive properties of several metabolic hormones, thus lowering blood glucose levels and  reducing body weight.
(rigth side, firsts speaker)

Shingo Kajimura seeks to develop pharmacological approaches to promote the development of the brown or beige adipose tissue - these two tissues produce energy by fat burning.
(left side, second speaker)

More about Kajimura:



In 2015, Prof. Matthew Rodeheffer from Yale University, USA was honored with this award for young rising stars. He investigates how obesity and fat masses are regulated with the aim of developing novel therapeutics of obesity and diabetes.

More about Rodeheffer:




Last year Dr. Zachary Knight from the University of California, SF/USA and Dr. Andrew Pospisilik from the Max Planck Institute of Immunobiology & Epigenetics, Germany were delighted to receive the HeIDi Award.

Zachary Knight studies neural circuits in mice that control feeding and other motivated behaviors central to survival. The goal of the lab's research is to understand how the circuits are able to sense the needs of the body, and thus generate specific behavioral responses that restore homeostasis.
(left side, first speaker)

Andrew Pospisilik investigates the influence of important regulatory levels, especially epigenetic regulation, on the development of diabetes.
(right side, second speaker)

More about Knight:


More about Pospisilik:


See you soon!

In a few days, on September 17-19 new rising stars of the diabetes scene will once again take center stage. Each one of them is making a major contribution to diabetes research. It is always amazing how these young researchers pursue new ideas to cure diabetes. Join their presentations and be part of the community when this year’s HeIDi Award winner will be selected. And that’s not all: top-researchers, who have been instrumental in shaping diabetes research for years, will give an overview of the development and status of their respective special research area.

It is remarkable how all of these researchers are addressing the worldwide challenge of diabetes. Together at this conference, they will benefit from the shared knowledge. They will pool it and generate new associations. The expertise and trust displayed during these three days will enable diabetes research to make a giant step forward

Join us as a participant in the Helmholtz-Nature Medicine Diabetes Conference – We look forward to seeing you!



Any suggestions or questions?

Tweet us @helmholtzMucEn